Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and distributes generic prescription pharmaceutical products

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products.

Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations.

It also provides laboratory services which involves analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. The company was founded in 1942 and is headquartered in Philadelphia, PA.
Managers
NameAgeSinceTitle
Arthur P. Bedrosian702000Chief Executive Officer & Director
Jeffrey Farber562003Chairman
Martin P. Galvan, CPA642011CFO, Treasurer & Vice President-Finance
Robert Ehlinger592006Chief Information Officer & VP-logistics
David A. Drabik482010Lead Independent Director
Paul Taveira562012Independent Director
James M. Maher632013Independent Director
Albert R. Paonessa III562015Independent Director
Kevin R. Smith562002Senior Vice President-Sales & Marketing
John Abt-2015Vice President-Quality
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 37,606,603 27,608,655 73.4% 604,866 1.6% 73.4%
Shareholders
NameEquities%
Telemus Capital LLC 6,482,126 17.6%
Jeffrey Farber 4,643,874 12.6%
David Farber 3,789,904 10.3%
BlackRock Fund Advisors 2,885,039 7.82%
The Vanguard Group, Inc. 2,490,659 6.75%
Snow Capital Management LP 2,117,912 5.74%
Deerfield Management Company LP 2,008,051 5.44%
Coatue Management LLC 1,580,790 4.28%
Invesco PowerShares Capital Management LLC 1,292,500 3.50%
SSgA Funds Management, Inc. 1,044,058 2.83%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.895
JOHNSON & JOHNSON9.00%304 591
PFIZER INC.-2.01%191 942
ROCHE HOLDING LTD.-19.61%188 878
NOVARTIS AG-19.07%178 737
MERCK & CO., INC.15.85%168 544
SANOFI-4.20%103 510
BRISTOL-MYERS SQUIBB C..-17.95%93 522
GLAXOSMITHKLINE PLC6.85%91 041
BAYER AG-25.06%76 831
ELI LILLY AND CO-20.34%74 748
ALLERGAN PLC-39.30%71 149
NOVO NORDISK A/S-41.01%68 352
ASTRAZENECA PLC-11.62%64 588
ABBOTT LABORATORIES-15.23%55 801
SHIRE PLC-3.05%52 210
TAKEDA PHARMACEUTICAL ..-22.03%32 564
ASTELLAS PHARMA INC-9.55%29 477
MYLAN NV-33.44%19 258
EISAI CO., LTD-16.80%17 197
SHIONOGI & CO LTD-2.08%16 452
Sector Pharmaceuticals - NEC
Lannett Company, Inc. : Connections
Lannett Co., Inc.
13200 Townsend Road
Philadelphia, PA 19154

Phone : +1.215.333.9000
Fax : +1.215.333.9004
Web : www.lannett.com
© 2016 People , Fundamentals and Ownership